MA71753A - Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble - Google Patents
Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase solubleInfo
- Publication number
- MA71753A MA71753A MA71753A MA71753A MA71753A MA 71753 A MA71753 A MA 71753A MA 71753 A MA71753 A MA 71753A MA 71753 A MA71753 A MA 71753A MA 71753 A MA71753 A MA 71753A
- Authority
- MA
- Morocco
- Prior art keywords
- intermediates
- preparation
- guanylate cyclase
- soluble guanylate
- novel processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862615678P | 2018-01-10 | 2018-01-10 | |
| PCT/CN2018/076982 WO2019161534A1 (fr) | 2018-02-22 | 2018-02-22 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
| EP25174051.0A EP4570797A3 (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA71753A true MA71753A (fr) | 2025-05-30 |
Family
ID=65279655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051565A MA51565A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble |
| MA71753A MA71753A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051565A MA51565A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US11274096B2 (fr) |
| EP (3) | EP4249469A3 (fr) |
| JP (2) | JP7357621B2 (fr) |
| KR (3) | KR102739727B1 (fr) |
| CN (3) | CN118221665A (fr) |
| AU (3) | AU2019206560B2 (fr) |
| BR (1) | BR112020013985A2 (fr) |
| CA (1) | CA3087943A1 (fr) |
| CL (3) | CL2020001814A1 (fr) |
| ES (1) | ES2963447T3 (fr) |
| IL (3) | IL319883A (fr) |
| JO (1) | JOP20200165A1 (fr) |
| MA (2) | MA51565A (fr) |
| MX (3) | MX2020007364A (fr) |
| SG (1) | SG11202006311SA (fr) |
| TW (2) | TWI821237B (fr) |
| WO (1) | WO2019140095A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3481818B1 (fr) * | 2016-07-07 | 2023-09-06 | Cyclerion Therapeutics, Inc. | Nouveaux procédés de préparation de stimulateurs de la guanylate cyclase soluble |
| EP4249469A3 (fr) | 2018-01-10 | 2023-12-27 | Cyclerion Therapeutics, Inc. | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble |
| WO2024131860A1 (fr) * | 2022-12-21 | 2024-06-27 | 广东东阳光药业股份有限公司 | Forme cristalline d'un composé indazole substitué par du fluor et son utilisation |
| AU2023412228A1 (en) * | 2022-12-21 | 2025-07-03 | Sunshine Lake Pharma Co., Ltd. | Crystal form of fluorine-substituted indazole compound and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA026692B1 (ru) * | 2010-06-30 | 2017-05-31 | Айронвуд Фармасьютикелз, Инк. | Стимуляторы sgc |
| RS63108B1 (sr) * | 2013-03-15 | 2022-04-29 | Cyclerion Therapeutics Inc | Sgc stimulatori |
| EP3094327A1 (fr) * | 2014-01-13 | 2016-11-23 | Ironwood Pharmaceuticals, Inc. | Utilisation de stimulateurs de la sgc pour le traitement de troubles neuromusculaires |
| CA2961531A1 (fr) * | 2014-09-17 | 2016-03-24 | Ironwood Pharmaceuticals, Inc. | Stimulateurs de la sgc |
| US20170291889A1 (en) | 2014-09-17 | 2017-10-12 | Ironwood Pharmaceuticals, Inc. | Pyrazole derivatives as sgc stimulators |
| BR112018011154B1 (pt) | 2015-11-30 | 2023-09-26 | Cyclerion Therapeutics, Inc | Dispersões sólidas compreendendo um estimulador de sgc |
| WO2018009602A2 (fr) | 2016-07-07 | 2018-01-11 | Ironwood Pharmaceuticals, Inc. | Nouveaux procédés de préparation de stimulateurs de la guanylate cyclase soluble |
| EP3481818B1 (fr) | 2016-07-07 | 2023-09-06 | Cyclerion Therapeutics, Inc. | Nouveaux procédés de préparation de stimulateurs de la guanylate cyclase soluble |
| EP4249469A3 (fr) | 2018-01-10 | 2023-12-27 | Cyclerion Therapeutics, Inc. | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble |
-
2019
- 2019-01-10 EP EP23187776.2A patent/EP4249469A3/fr active Pending
- 2019-01-10 US US16/961,109 patent/US11274096B2/en active Active
- 2019-01-10 EP EP19703440.8A patent/EP3737679B1/fr active Active
- 2019-01-10 CN CN202410363184.1A patent/CN118221665A/zh active Pending
- 2019-01-10 CA CA3087943A patent/CA3087943A1/fr active Pending
- 2019-01-10 MA MA051565A patent/MA51565A/fr unknown
- 2019-01-10 WO PCT/US2019/013060 patent/WO2019140095A1/fr not_active Ceased
- 2019-01-10 KR KR1020207022640A patent/KR102739727B1/ko active Active
- 2019-01-10 TW TW108101044A patent/TWI821237B/zh active
- 2019-01-10 MA MA71753A patent/MA71753A/fr unknown
- 2019-01-10 SG SG11202006311SA patent/SG11202006311SA/en unknown
- 2019-01-10 AU AU2019206560A patent/AU2019206560B2/en active Active
- 2019-01-10 ES ES19703440T patent/ES2963447T3/es active Active
- 2019-01-10 JO JOP/2020/0165A patent/JOP20200165A1/ar unknown
- 2019-01-10 TW TW112138274A patent/TWI888947B/zh active
- 2019-01-10 BR BR112020013985-8A patent/BR112020013985A2/pt active Search and Examination
- 2019-01-10 KR KR1020257010603A patent/KR20250048609A/ko active Pending
- 2019-01-10 MX MX2020007364A patent/MX2020007364A/es unknown
- 2019-01-10 CN CN202410363182.2A patent/CN118184645A/zh active Pending
- 2019-01-10 IL IL319883A patent/IL319883A/en unknown
- 2019-01-10 CN CN201980017700.2A patent/CN111902410B/zh active Active
- 2019-01-10 JP JP2020538535A patent/JP7357621B2/ja active Active
- 2019-01-10 KR KR1020247039985A patent/KR20250002720A/ko active Pending
- 2019-01-10 IL IL275748A patent/IL275748B2/en unknown
- 2019-01-10 IL IL314714A patent/IL314714A/en unknown
- 2019-01-10 EP EP25174051.0A patent/EP4570797A3/fr active Pending
-
2020
- 2020-07-07 CL CL2020001814A patent/CL2020001814A1/es unknown
- 2020-07-13 MX MX2023000044A patent/MX2023000044A/es unknown
- 2020-07-13 MX MX2023000045A patent/MX2023000045A/es unknown
-
2021
- 2021-10-08 US US17/497,352 patent/US11708361B2/en active Active
-
2022
- 2022-04-08 CL CL2022000907A patent/CL2022000907A1/es unknown
- 2022-04-08 CL CL2022000904A patent/CL2022000904A1/es unknown
-
2023
- 2023-04-28 US US18/140,966 patent/US12030874B2/en active Active
- 2023-09-26 JP JP2023162922A patent/JP7744955B2/ja active Active
- 2023-11-22 AU AU2023270260A patent/AU2023270260B2/en active Active
-
2024
- 2024-05-22 US US18/671,182 patent/US12275724B2/en active Active
-
2025
- 2025-03-31 AU AU2025202281A patent/AU2025202281A1/en active Pending
- 2025-04-11 US US19/176,742 patent/US20250361228A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3504196A4 (fr) | Procédés de préparation d'olaparib | |
| EP3402787A4 (fr) | Procédés de préparation d'acide 2,5-furandicarboxylique et des intermédiaires et dérivés correspondants | |
| MA55082A (fr) | Compositions, procédés, et kits pour l'administration de polyribonucléotides | |
| EP3749769A4 (fr) | Procédés de production d'alcaloïdes de type morphinane et de dérivés | |
| MA46479A (fr) | Procédés et intermédiaires pour la préparation de nouveaux composés substitués de 6,7-dihydro-5h-benzo[7]annulène | |
| MA46240A (fr) | Compositions d'arn de haute pureté et procédés pour leur préparation | |
| EP3893655A4 (fr) | Procédés pour la préparation d'un composition de protéines végétales | |
| EP3315512A4 (fr) | Procédé pour la préparation sélective d'un conjugué anticorps-médicament | |
| MA71753A (fr) | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble | |
| EP3635022A4 (fr) | Procédés de préparation de monomères fluorés fonctionnalisés, monomères fluorés et compositions pour les préparer | |
| EP3294865A4 (fr) | Procédés de production d'épimérases et d'alcaloïdes benzylisoquinoléine | |
| EP3529232A4 (fr) | Dérivés d'acide sulfamique et procédés pour leur préparation | |
| MA53445A (fr) | Procédés et compositions pour la modification de plantes | |
| EP3645049A4 (fr) | Anticorps multispécifiques et procédés de préparation et d'utilisation associés | |
| EP3675847A4 (fr) | Composés spirocycliques et procédés de préparation et d'utilisation de ceux-ci | |
| EP3897717A4 (fr) | Procédés de production d'anticorps hétérodimères | |
| MA53391A (fr) | Compositions pour l'agriculture et procédés associés | |
| EP3720456A4 (fr) | Procédés d'enrichissement améliorés pour la préparation de compositions d'acide tannique | |
| EP3466280A4 (fr) | Procédé de préparation d'aliments transformés et aliments transformés préparés au moyen de ce procédé | |
| MA51307A (fr) | Compositions laitières fermentées et procédés de préparation de celles-ci | |
| EP3645548A4 (fr) | Procédés de préparation d'acides biliaires | |
| EP3803416A4 (fr) | Compositions et procédés de détection d'une lésion cérébrale traumatique | |
| EP3889572A4 (fr) | Procédé de préparation d'échantillon | |
| IL263994B (en) | Novel processes for preparation of soluble guanylate cyclase stimulators | |
| EP3314001A4 (fr) | Procédés et compositions pour la préparation d'éphédrine et de composés alcaloïdes apparentés |